This inventor holds 1 USPTO granted patent. Top assignee: Ark Therapeutics Limited. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Anssi Mahonen: Innovator in Viral Vector Technology
Introduction
Anssi Mahonen is a notable inventor based in Kuopio, Finland. He has made significant contributions to the field of viral vector technology, particularly in the development of avidin-pseudotyped viral vectors. His work has implications for gene delivery systems, which are crucial in various biotechnological applications.
Latest Patents
Anssi Mahonen holds a patent for "Avidin-pseudotyped viral vectors and their use." This invention pertains to an avidin-pseudotyped virus, specifically baculovirus, which is useful for the delivery of foreign genes. The patent also includes vectors comprising respective cassettes for pseudotyping, mammalian gene expression, and insect gene expression in baculovirus. He has 1 patent to his name.
Career Highlights
Anssi Mahonen is associated with Ark Therapeutics Limited, where he continues to advance his research in viral vector technology. His work at the company has positioned him as a key figure in the development of innovative gene delivery systems.
Collaborations
Anssi has collaborated with notable colleagues such as Kari Juhani Airenne and Seppo Yla-Herttuala. These collaborations have further enriched his research and contributed to advancements in the field.
Conclusion
Anssi Mahonen's contributions to viral vector technology highlight his role as an innovator in the biotechnology sector. His patent on avidin-pseudotyped viral vectors showcases his commitment to advancing gene delivery systems.